Molecular predisposition and environmental factors in development of diffuse large B cell lymphoma
DOI:
https://doi.org/10.47611/jsrhs.v13i3.7220Keywords:
Diffuse Large B cell Lymphoma, DLBCL, cancer, prevention, CAR-T, R-CHOP, carcinogen, genetic predispositionAbstract
Due to increased amounts of industrial and food related carcinogens, rising rates of cancers such as Diffuse Large B Cell Lymphoma pose a serious threat to the wellbeing of people. Although cases of Diffuse Large B Cell Lymphoma (DLBCL) are found globally, a staggering majority of the cases are found in developed nations, such as the United States and United Kingdom. Current research on DLBCL mostly focuses on potential cures rather than on preventative measures individuals can take. Additionally, DLBCL, a type of non-Hodgkin's Lymphoma, is a diffused cancer. This means the cancerous cells travel all over the body through the lymphatic system. DLBCL has one of the highest rates of metastasis because the lymphatic system is connected to all organs in the body. After in-depth research into the impacts of genetic predisposition, environmental causation, and lifestyle habits on DLBCL lymphatogenesis, a research-backed map was created to help guide individuals with DLBCL genetic predisposition, who are exposed to certain carcinogens through food and drink, and the average inhabitant of developed countries to living lives that are preventative to DLBCL. This paper concludes that factors such as genetic testing, dietary changes including reduced consumption of bovine milk and edible dyes, and limited exposure to certain environmental carcinogens such as benzene all allow individuals to be proactive about their health. This research allows individuals who are concerned about their chances of developing cancer to understand and employ preventative measures into their lives, effectively preventing, stabilizing, or halting the development of any DLBCL.
Downloads
References or Bibliography
Wang, S. S. (2023). Epidemiology and etiology of diffuse large B-cell lymphoma. Seminars in Hematology. https://doi.org/10.1053/j.seminhematol.2023.11.004
American, C. S. (2019). Annual cancer facts and figures archives. Cancer.org; American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures.html
Yanguas-Casás, N., Pedrosa, L., Fernández-Miranda, I., & Sánchez-Beato, M. (2021). An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach. Cancers, 13(12), 2893. https://doi.org/10.3390/cancers13122893
Pasqualucci, L., & Dalla-Favera, R. (2018). Genetics of diffuse large B-cell lymphoma. Blood, 131(21), 2307–2319. https://doi.org/10.1182/blood-2017-11-764332
Zhou, H., Du, X., Tang, Y., Wu, J., Liu, W., Yi, Y., Dai, L., Ouyang, Z., Deng, M., Guan, Y.-F., Yi, X., Yang, L., & Xia, X. (2018). Discover BCL6 translocations partner gene in diffuse large b-cell lymphoma by target-captured next generation sequencing.. Journal of Clinical Oncology, 36(15_suppl), e19527–e19527. https://doi.org/10.1200/jco.2018.36.15_suppl.e19527
Ohno, H. (2004). Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin’s lymphoma. Histology and Histopathology, 19(2), 637–650. https://doi.org/10.14670/HH-19.637
Bassig, B. A., Lan, Q., Rothman, N., Zhang, Y., & Zheng, T. (2012). Current Understanding of Lifestyle and Environmental Factors and Risk of Non-Hodgkin Lymphoma: An Epidemiological Update. Journal of Cancer Epidemiology, 2012, 1–27. https://doi.org/10.1155/2012/978930
Moubadder, L., McCullough, L. E., Flowers, C. R., & Koff, J. L. (2020). Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes. Cancer Epidemiology and Prevention Biomarkers. https://doi.org/10.1158/1055-9965.EPI-20-0228
Wu, H.-C., Cohn, B. A., Cirillo, P. M., Santella, R. M., & Terry, M. B. (2020). DDT exposure during pregnancy and DNA methylation alterations in female offspring in the Child Health and Development Study. Reproductive Toxicology, 92, 138–147. https://doi.org/10.1016/j.reprotox.2019.02.010
Does Roundup Cause Non-Hodgkin Lymphoma? (2023, February 13). Www.patientpower.info. https://www.patientpower.info/non-hodgkin-lymphoma/roundup-non-hodgkin-lymphoma
Liu, Y., Feng, J., Yuan, K., Wu, Z., Hu, L., Lu, Y., Li, K., Guo, J., Chen, J., Ma, C., & Pang, X. (2022). The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress. ELife, 11. https://doi.org/10.7554/elife.69255
Melnik, B. C., Stadler, R., Ralf Weiskirchen, Claus Leitzmann, & Schmitz, G. (2023). Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences, 24(7), 6102–6102. https://doi.org/10.3390/ijms24076102
Dwivedi, K., & Kumar, G. (2015). Genetic Damage Induced by a Food Coloring Dye (Sunset Yellow) on Meristematic Cells ofBrassica campestrisL. Journal of Environmental and Public Health, 2015, 1–5. https://doi.org/10.1155/2015/319727
American Cancer Society. (2020, May 1). Chemotherapy Side Effects | American Cancer Society. Www.cancer.org; American Cancer Society. https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/chemotherapy-side-effects.html
Modi, D., Potugari, B., & Uberti, J. (2021). Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions. Cancers, 13(22), 5827. https://doi.org/10.3390/cancers13225827
Matulis, S. M., & Boise, L. H. (2020). BCL2 dependency in diffuse large B-cell lymphoma: it’s a family affair. Haematologica, 105(8), 1993–1996. https://doi.org/10.3324/haematol.2020.253591
Frontzek, F., Karsten, I., Schmitz, N., & Lenz, G. (2022). Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma. Therapeutic Advances in Hematology, 13, 20406207221103321. https://doi.org/10.1177/20406207221103321
Choi, K.-H., Lee, S.-J., Mun, S.-H., Song, J.-H., & Choi, B.-O. (2023). Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis. Cancers (Basel), 15(15), 3940–3940. https://doi.org/10.3390/cancers15153940
Ritter, A. J., Goldstein, J. S., Ayers, A. A., & Flowers, C. R. (2019). Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study. Leukemia & Lymphoma, 60(7), 1656–1667. https://doi.org/10.1080/10428194.2018.1546855
Rosenberg, S., & National Cancer Institute (NCI). (2021, December 29). An Assessment of the Safety and Feasibility of Administering T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor to Patients With B-Cell Lymphoma. Clinicaltrials.gov. https://clinicaltrials.gov/study/NCT00924326?cond=DLBCL%20-%20Diffuse%20Large%20B%20Cell%20Lymphoma&intr=CAR-T&aggFilters=results:with&rank=7&tab=results#results-overview
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dia Patil; Coach Jo, Dr. Prahlad Parajuli

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.